
Release date: 2026-04-10 17:54:04 Article From: Lucius Laos Recommended: 7
Gilteritinib can be taken comfortably at home. Follow your healthcare provider's instructions carefully: take one dose at approximately the same time every day, swallow the tablet whole without breaking, crushing, or chewing; it can be taken with or without food. If you miss a dose, take it as soon as possible on the same day, making sure there are at least 12 hours before your next scheduled dose, then resume your normal schedule the next day. Never take two doses within 12 hours. It may take some time for you to respond to gilteritinib. As long as the disease is not progressing and no serious side effects occur, doctors typically recommend taking the medication for at least 6 consecutive months. Any dose adjustments or decisions to stop the medication must be discussed with your doctor in advance.
Gilteritinib can be taken at home, which offers convenience but also places greater demands on self‑management. It is recommended to take the medication at a fixed time every day, for example, setting a mobile phone alarm as a reminder. If you occasionally miss a dose, take it as soon as possible on the same day, ensuring there are at least 12 hours before your next scheduled dose, then resume your normal schedule the next day. Never take two doses within 12 hours. In addition to taking the medication on time, you can ask family members to help record daily symptoms, such as whether you experience fever, cough, shortness of breath, rash, dizziness, swelling of the limbs, or decreased urine output. If possible, try to maintain your usual hobbies and interests — even just listening to music or reading a few pages of a book each day can help maintain a positive mindset. Cancer treatment is a long battle; a regular daily routine can give you a greater sense of control.
While using gilteritinib, understanding the severity of different side effects helps you respond promptly. The most concerning condition is differentiation syndrome, which presents as fever, cough, difficulty breathing, rash, dizziness, rapid weight gain, swelling of the limbs, or decreased urine output. If any of these occur, seek immediate medical attention. Other situations that also require urgent attention include: seizures, severe headache with blurred vision (which may indicate posterior reversible encephalopathy syndrome), fainting or palpitations (which may indicate abnormal heart electrical activity), and unrelieved severe abdominal pain (which may indicate pancreatitis). In comparison, more common side effects such as joint and muscle aches, fatigue, nausea, diarrhea, constipation, mouth ulcers, and elevated liver function tests, while not life‑threatening, should still be reported to your doctor promptly. The doctor may adjust the dose or provide supportive care. Do not stop or reduce your dose on your own due to fear of side effects; any adjustments should be made under the guidance of your medical team.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:2302025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4572024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:2392025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:2512025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:2292025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:2612025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:2392025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:2232025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: